Abstract
Introduction: Thoracic aortic calcification (TAC) is associated with an increased atherosclerotic cardiovascular disease (ASCVD) risk, but it is unclear how to interpret TAC findings in conjunction with ASCVD risk and coronary artery calcium (CAC) score. We evaluated the implication of TAC over CAC for reclassifying statin eligibility groups according to 2018 ACC/AHA cholesterol management guidelines.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
